Skip to content

2023 # 490 Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors

CMS Measure ID: #490 Collection Type: CQM Reporting Frequency: Once per episode of treatment Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 490 Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors”

2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)

CMS Measure ID: #457 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: Yes High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)”

2023 # 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)

CMS Measure ID: #453 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)”

2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies

CMS Measure ID: #452 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Patient Safety MeasureContinue reading “2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies”

2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy

CMS Measure ID: #451 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy”

2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer

CMS Measure ID: #450 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer”